- Becton Dickinson
- Overview
- Last Modified:
- November 11, 2025
- Company type:
- Public
- Industry:
- Healthcare
- Verified:
- No
- No of Employees:
- 50 001 - 100 000
- Stock Code:
- BDX
- Download
- Signed Health Status Declaration Form
- Turnover $50m + ?:
- Yes
- Headquarters:
- Franklin Lakes, New Jersey
- Public Interest Score:
- 750+
- Becton Dickinson
- General Information
Description
BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures and support the management of diabetes.
The company partners with organizations around the world to address some of the most challenging global health issues. BD has more than 65,000 associates across 50 countries who work in close collaboration with customers and partners to help enhance outcomes, lower health care delivery costs, increase efficiencies, improve health care safety and expand access to health.
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
William Brown:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Catherine Burzik:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Carrie Byington:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Andrew Eckert:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Claire Fraser:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Jeffrey Henderson:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Christopher Jones:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Timothy Ring:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Bertram Scott:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Joanne Waldstreicher:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Gregory Hayes:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Subsribe/ Login to view details on company risk rating
5 Benchmark > 4 Excellent > 3Â Good > 2 Caution > 1 Risk
- Company Information
- Company System Number:
- 14859
- Founded Year:
- 1897
- Registration Number:
- 22-0760120
- Country:
- United States of America
- Stock Exchanges:
-
- New York Stock Exchange
- Financial year end:
- September
- No. of Countries operations:
- 50
- Company Status:
- In Business
- Industry Sub Category:
- Medical Technology
- Date listed on Stock Exchange:
- 23/04/1962
- Contact Information
- Business operation:
- BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues. BD has more than 65,000 associates across 50 countries who work in close collaboration with customers and partners to help enhance outcomes, lower health care delivery costs, increase efficiencies, improve health care safety and expand access to health.
- Primary office:
- BD 1 Becton Drive Franklin Lakes, NJ USA 07417 …
- Additional Information
- Listed?:
- Yes
- Company secretary:
- Gary DeFazio
- Reporting currency:
- USD
- ISIN number (12 digit):
NYSE
US0758871091- Authorised shares:
- 640 000 000
- Issued shares:
- 370 594 401
- No of shareholders:
- 1001 and more shareholders
- No of shareholders holding 20%:
- 0 shareholders
- Number of shares traded
- Per Year:
- Per Quarter:
- Per Month:
Shareholders holding 5% +
For a comprehensive list, please contact InsidEntity.
Material Subsidiaries/Associates
For a comprehensive list, please contact InsidEntity.
Credit Rating
| Name | Logo | Country | Headquarters | Rating |
|---|---|---|---|---|
| Moodys | ![]() | United States of America | New York | Baa3 |
| Fitch Ratings | ![]() | United States of America | New York | BBB- |
Countries Operations/ Offices
Company Directors
Thomas
ExecutiveBertram
Executive
Directors Tenure
Director Experience
Company Auditors
Ernst & Young
Company Committees
|
Committee
|
Abbreviation
|
|---|---|
|
Supervisory Board
|
SB
|
|
Board
|
BD
|
|
Risk & Compliance
|
RC
|
|
Audit
|
AU
|
|
Remuneration
|
RE
|
|
Capital investment
|
CI
|
|
Industry Specific
|
IS
|
|
Nominations & Governance
|
NG
|
|
Health, Safety & Environment
|
HS
|
|
Social & Ethics
|
SE
|
|
Technology
|
TE
|
|
Executive
|
EX
|
|
Other
|
OT
|


